Immunogenicity and safety study of a new DTaP-IPV-Hep B-PRP-T combined vaccine compared to a licensed DTaP-IPV-Hep B//PRP-T comparator, both concomitantly administered with a 7-valent pneumococcal conjugate vaccine at 2, 4, and 6 months of age in Thai infants. [electronic resource]
Producer: 20110713Description: e249-56 p. digitalISSN:- 1878-3511
- Antibodies, Bacterial -- blood
- Antibodies, Viral -- blood
- Diphtheria-Tetanus-acellular Pertussis Vaccines -- administration & dosage
- Drug Therapy, Combination
- Haemophilus Vaccines -- administration & dosage
- Hepatitis B Vaccines -- administration & dosage
- Heptavalent Pneumococcal Conjugate Vaccine
- Humans
- Immunization Schedule
- Infant
- Pneumococcal Vaccines -- administration & dosage
- Poliovirus Vaccine, Inactivated -- administration & dosage
- Thailand
- Treatment Outcome
- Vaccination
- Vaccines, Combined -- administration & dosage
- Vaccines, Conjugate -- administration & dosage
No physical items for this record
Publication Type: Clinical Trial, Phase III; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.